Info@eximtradedata.com

Latest Turkey Import Data of Advanced under HS Code 3002

Access the latest Turkey import data of Advanced under HS code 3002. Track and monitor the buyers, competitors shipment activities based on Turkey shipment data of Advanced under HS Code 3002. Analyze product demand, pricing and buyer’s buying behavior through our useful data insights and boost you sales in the Turkey’s market.

Filters
DateHS CodeProduct DetailsQuantityUnitTotal Value (USD)PortBuyer
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19382N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA6UNIT28720N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA10UNIT47649N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/28/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19277N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19266N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19251N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA2UNIT9982N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA8UNIT38516N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA10UNIT47958N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA2UNIT9697N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
Know your Market & Competitor
Get Genuine Business Leads
Achieve your business goals
Customized Indonesia Data Reports
Fast & Reliable Services